DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017" report to their offering.
The results of the Small Cell Lung Cancer patients study are announced in this new report Global Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017'. The report provides insights into Small Cell Lung Cancer epidemiology, Small Cell Lung Cancer diagnosed patients, and Small Cell Lung Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Small Cell Lung Cancer derived from epidemiological analysis, percentage of patients diagnosed with Small Cell Lung Cancer, and percentage of patients treated with a therapy.
The study helps executives estimate Small Cell Lung Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Small Cell Lung Cancer prevalence, Small Cell Lung Cancer diagnosis rate, and Small Cell Lung Cancer treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.
Key Features of the Report:
- Small Cell Lung Cancer Patient Flow
- Small Cell Lung Cancer Prevalence
- Small Cell Lung Cancer Diagnosed Patients
-
Small Cell Lung Cancer Treated Patients
Key Topics Covered:
1. Small Cell Lung Cancer: Disease Definition
2. Global Small Cell Lung Cancer Patient Flow
2A. Global Small Cell Lung Cancer Prevalence
2B. Global Small Cell Lung Cancer Diagnosed Patients
2C. Global Small Cell Lung Cancer Treated Patients
3. Small Cell Lung Cancer Patient Flow in the US
3A. Small Cell Lung Cancer Prevalence in the US
3B. Small Cell Lung Cancer Diagnosed Patients in the US
3C. Small Cell Lung Cancer Treated Patients in the US
4. Small Cell Lung Cancer Patient Flow in Europe
4A. Small Cell Lung Cancer Prevalence in Europe
4B. Small Cell Lung Cancer Diagnosed Patients in Europe
4C. Small Cell Lung Cancer Treated Patients in Europe
5. Small Cell Lung Cancer Patient Flow in Germany
5A. Small Cell Lung Cancer Prevalence in Germany
5B. Small Cell Lung Cancer Diagnosed Patients in Germany
5C. Small Cell Lung Cancer Treated Patients in Germany
6. Small Cell Lung Cancer Patient Flow in France
6A. Small Cell Lung Cancer Prevalence in France
6B. Small Cell Lung Cancer Diagnosed Patients in France
6C. Small Cell Lung Cancer Treated Patients in France
7. Small Cell Lung Cancer Patient Flow in Spain
7A. Small Cell Lung Cancer Prevalence in Spain
7B. Small Cell Lung Cancer Diagnosed Patients in Spain
7C. Small Cell Lung Cancer Treated Patients in Spain
8. Small Cell Lung Cancer Patient Flow in Italy
8A. Small Cell Lung Cancer Prevalence in Italy
8B. Small Cell Lung Cancer Diagnosed Patients in Italy
8C. Small Cell Lung Cancer Treated Patients in Italy
9. Small Cell Lung Cancer Patient Flow in UK
9A. Small Cell Lung Cancer Prevalence in UK
9B. Small Cell Lung Cancer Diagnosed Patients in UK
9C. Small Cell Lung Cancer Treated Patients in UK
10. Small Cell Lung Cancer Patient Flow in Japan
10A. Small Cell Lung Cancer Prevalence in Japan
10B. Small Cell Lung Cancer Diagnosed Patients in Japan
10C. Small Cell Lung Cancer Treated Patients in Japan
11. Research Methodology
For more information about this report visit http://www.researchandmarkets.com/research/bzhb3w/global_small_cell